HFR2 Signatures in Breast Cancer: Ready to Go to Print?

被引:7
作者
Eichhorn, Pieter J. A. [1 ]
Baselga, Jose [1 ]
机构
[1] Univ Autonoma Barcelona, Vall Hebron Univ Hosp, Vall Hebron Inst Oncol, E-08193 Barcelona, Spain
关键词
RESISTANCE; SURVIVAL;
D O I
10.1200/JCO.2009.26.7146
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1809 / 1810
页数:2
相关论文
共 9 条
[1]   A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer [J].
Berns, Katrien ;
Horlings, Hugo M. ;
Hennessy, Bryan T. ;
Madiredjo, Mandy ;
Hijmans, E. Marielle ;
Beelen, Karin ;
Linn, Sabine C. ;
Gonzalez-Angulo, Ana Maria ;
Stemke-Hale, Katherine ;
Hauptmann, Michael ;
Beijersbergen, Roderick L. ;
Mills, Gordon B. ;
de Vijver, Marc J. van ;
Bernards, Rene .
CANCER CELL, 2007, 12 (04) :395-402
[2]   Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235 [J].
Eichhorn, Pieter J. A. ;
Gili, Magui ;
Scaltriti, Maurizio ;
Serra, Violeta ;
Guzman, Marta ;
Nijkamp, Wouter ;
Beijersbergen, Roderick L. ;
Valero, Vanesa ;
Seoane, Joan ;
Bernards, Rene ;
Baselga, Jose .
CANCER RESEARCH, 2008, 68 (22) :9221-9230
[3]   A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer [J].
Paik, S ;
Shak, S ;
Tang, G ;
Kim, C ;
Baker, J ;
Cronin, M ;
Baehner, FL ;
Walker, MG ;
Watson, D ;
Park, T ;
Hiller, W ;
Fisher, ER ;
Wickerham, DL ;
Bryant, J ;
Wolmark, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2817-2826
[4]   Molecular portraits of human breast tumours [J].
Perou, CM ;
Sorlie, T ;
Eisen, MB ;
van de Rijn, M ;
Jeffrey, SS ;
Rees, CA ;
Pollack, JR ;
Ross, DT ;
Johnsen, H ;
Akslen, LA ;
Fluge, O ;
Pergamenschikov, A ;
Williams, C ;
Zhu, SX ;
Lonning, PE ;
Borresen-Dale, AL ;
Brown, PO ;
Botstein, D .
NATURE, 2000, 406 (6797) :747-752
[5]  
Slamon D J, 1990, Cancer Invest, V8, P253, DOI 10.3109/07357909009017573
[6]   HUMAN-BREAST CANCER - CORRELATION OF RELAPSE AND SURVIVAL WITH AMPLIFICATION OF THE HER-2 NEU ONCOGENE [J].
SLAMON, DJ ;
CLARK, GM ;
WONG, SG ;
LEVIN, WJ ;
ULLRICH, A ;
MCGUIRE, WL .
SCIENCE, 1987, 235 (4785) :177-182
[7]   Identification of Subtypes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome [J].
Staaf, Johan ;
Ringner, Markus ;
Vallon-Christersson, Johan ;
Jonsson, Goran ;
Bendahl, Par-Ola ;
Holm, Karolina ;
Arason, Adalgeir ;
Gunnarsson, Haukur ;
Hegardt, Cecilia ;
Agnarsson, Bjarni A. ;
Luts, Lena ;
Grabau, Dorthe ;
Ferno, Marten ;
Malmstrom, Per-Olof ;
Johannsson, Oskar Th. ;
Loman, Niklas ;
Barkardottir, Rosa B. ;
Borg, Ake .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (11) :1813-1820
[8]   A gene-expression signature as a predictor of survival in breast cancer. [J].
van de Vijver, MJ ;
He, YD ;
van 't Veer, LJ ;
Dai, H ;
Hart, AAM ;
Voskuil, DW ;
Schreiber, GJ ;
Peterse, JL ;
Roberts, C ;
Marton, MJ ;
Parrish, M ;
Atsma, D ;
Witteveen, A ;
Glas, A ;
Delahaye, L ;
van der Velde, T ;
Bartelink, H ;
Rodenhuis, S ;
Rutgers, ET ;
Friend, SH ;
Bernards, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) :1999-2009
[9]   Gene expression profiling predicts clinical outcome of breast cancer [J].
van't Veer, LJ ;
Dai, HY ;
van de Vijver, MJ ;
He, YDD ;
Hart, AAM ;
Mao, M ;
Peterse, HL ;
van der Kooy, K ;
Marton, MJ ;
Witteveen, AT ;
Schreiber, GJ ;
Kerkhoven, RM ;
Roberts, C ;
Linsley, PS ;
Bernards, R ;
Friend, SH .
NATURE, 2002, 415 (6871) :530-536